BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9832162)

  • 1. Cross-linking sites of the human tau protein, probed by reactions with human transglutaminase.
    Murthy SN; Wilson JH; Lukas TJ; Kuret J; Lorand L
    J Neurochem; 1998 Dec; 71(6):2607-14. PubMed ID: 9832162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase cross-linking of the tau protein.
    Miller ML; Johnson GV
    J Neurochem; 1995 Oct; 65(4):1760-70. PubMed ID: 7561874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
    Dudek SM; Johnson GV
    J Neurochem; 1993 Sep; 61(3):1159-62. PubMed ID: 8103081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
    Appelt DM; Balin BJ
    Brain Res; 1997 Jan; 745(1-2):21-31. PubMed ID: 9037390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxynitrite-mediated tau modifications stabilize preformed filaments and destabilize microtubules through distinct mechanisms.
    Reynolds MR; Lukas TJ; Berry RW; Binder LI
    Biochemistry; 2006 Apr; 45(13):4314-26. PubMed ID: 16566606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
    Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual structure in the repeat domain of tau: echoes of microtubule binding and paired helical filament formation.
    Eliezer D; Barré P; Kobaslija M; Chan D; Li X; Heend L
    Biochemistry; 2005 Jan; 44(3):1026-36. PubMed ID: 15654759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
    Reynolds MR; Berry RW; Binder LI
    Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase-catalyzed formation of Alzheimer-like insoluble complexes from recombinant tau.
    Balin BJ; Appelt DM
    Methods Mol Med; 2000; 32():395-404. PubMed ID: 21318534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination.
    Tucholski J; Kuret J; Johnson GV
    J Neurochem; 1999 Nov; 73(5):1871-80. PubMed ID: 10537045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
    Norlund MA; Lee JM; Zainelli GM; Muma NA
    Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping.
    Paudel HK; Li W
    J Biol Chem; 1999 Mar; 274(12):8029-38. PubMed ID: 10075702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease.
    Citron BA; SantaCruz KS; Davies PJ; Festoff BW
    J Biol Chem; 2001 Feb; 276(5):3295-301. PubMed ID: 11013236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 2-Catalyzed Intramolecular Cross-Linking of Osteopontin.
    Christensen B; Zachariae ED; Scavenius C; Kløverpris S; Oxvig C; Petersen SV; Enghild JJ; Sørensen ES
    Biochemistry; 2016 Jan; 55(2):294-303. PubMed ID: 26678563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific derivatization of avidin using microbial transglutaminase.
    Spolaore B; Damiano N; Raboni S; Fontana A
    Bioconjug Chem; 2014 Mar; 25(3):470-80. PubMed ID: 24517223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase reactivity of human involucrin.
    Lambert A; Ekambaram M; Robinson N; Eckert RL
    Skin Pharmacol Appl Skin Physiol; 2000; 13(1):17-30. PubMed ID: 10657763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of in vitro glycation sites of tau.
    Nacharaju P; Ko L; Yen SH
    J Neurochem; 1997 Oct; 69(4):1709-19. PubMed ID: 9326300
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.